Literature DB >> 22448687

Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part I: Description and rationale.

Andrew E Skodol1, Lee Anna Clark, Donna S Bender, Robert F Krueger, Leslie C Morey, Roel Verheul, Renato D Alarcon, Carl C Bell, Larry J Siever, John M Oldham.   

Abstract

A major reconceptualization of personality psychopathology has been proposed for DSM-5 that identifies core impairments in personality functioning, pathological personality traits, and prominent pathological personality types. A comprehensive personality assessment consists of four components: levels of personality functioning, personality disorder types, pathological personality trait domains and facets, and general criteria for personality disorder. This four-part assessment focuses attention on identifying personality psychopathology with increasing degrees of specificity, based on a clinician's available time, information, and expertise. In Part I of this two-part article, we describe the components of the new model and present brief theoretical and empirical rationales for each. In Part II, we will illustrate the clinical application of the model with vignettes of patients with varying degrees of personality psychopathology, to show how assessments might be conducted and diagnoses reached.

Entities:  

Mesh:

Year:  2011        PMID: 22448687     DOI: 10.1037/a0021891

Source DB:  PubMed          Journal:  Personal Disord        ISSN: 1949-2723


  46 in total

1.  Pathological personality traits modulate neural interactions.

Authors:  Lisa M James; Brian E Engdahl; Arthur C Leuthold; Robert F Krueger; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2015-08-30       Impact factor: 1.972

2.  Personality disorders and the persistence of substance use disorders: A reanalysis of published NESARC findings.

Authors:  Alvaro Vergés; Kristina M Jackson; Kathleen K Bucholz; Timothy J Trull; Sean P Lane; Kenneth J Sher
Journal:  J Abnorm Psychol       Date:  2014-10-13

Review 3.  Personality disorders in DSM-5: emerging research on the alternative model.

Authors:  Leslie C Morey; Kathryn T Benson; Alexander J Busch; Andrew E Skodol
Journal:  Curr Psychiatry Rep       Date:  2015-04       Impact factor: 5.285

Review 4.  Sex Differences in Personality Disorders.

Authors:  Barbara Schulte Holthausen; Ute Habel
Journal:  Curr Psychiatry Rep       Date:  2018-10-11       Impact factor: 5.285

5.  An empirical examination of distributional assumptions underlying the relationship between personality disorder symptoms and personality traits.

Authors:  Aidan G C Wright; Aaron L Pincus; Mark F Lenzenweger
Journal:  J Abnorm Psychol       Date:  2012-06-25

6.  Replication of the Self-Concept and Identity Measure (SCIM) Among a Treatment-Seeking Sample.

Authors:  Erin A Kaufman; Megan E Puzia; Sheila E Crowell; Cynthia J Price
Journal:  Identity (Mahwah, N J)       Date:  2019-01-27

7.  Disorganized attachment and personality functioning in adults: A latent class analysis.

Authors:  Joseph E Beeney; Aidan G C Wright; Stephanie D Stepp; Michael N Hallquist; Sophie A Lazarus; Julie R S Beeney; Lori N Scott; Paul A Pilkonis
Journal:  Personal Disord       Date:  2016-03-17

8.  Obsessive compulsive personality disorder as a predictor of exposure and ritual prevention outcome for obsessive compulsive disorder.

Authors:  Anthony Pinto; Michael R Liebowitz; Edna B Foa; H Blair Simpson
Journal:  Behav Res Ther       Date:  2011-05-10

9.  Predicting problematic alcohol use with the DSM-5 alternative model of personality pathology.

Authors:  Kasey G Creswell; Rachel L Bachrach; Aidan G C Wright; Anthony Pinto; Emily Ansell
Journal:  Personal Disord       Date:  2015-09-21

10.  Incremental validity of the PID-5 in relation to the five factor model and traditional polythetic personality criteria of the DSM-5.

Authors:  J Christopher Fowler; Michelle A Patriquin; Alok Madan; Jon G Allen; B Christopher Frueh; John M Oldham
Journal:  Int J Methods Psychiatr Res       Date:  2016-09-27       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.